Treatment and prevention of bleeding from varicose veins of the esophagus
https://doi.org/10.29235/1818-9857-2021-1-80-83
Abstract
Liver cirrhosis is the result of various chronic liver diseases. Portal hypertension is a serious complication of cirrhosis. Its consequences, in turn, along with other complications are gastroesophageal varicose bleeding, which cause high mortality rates. The article contains analysis of the results of laparoscopic esophagogastric devascularization without esophageal transsection and splenectomy in a patient with liver cirrhosis portal hypertension and recurrent bleeding from varicose veins of the esophagus. First successful surgery according to this method was introduced in the Grodno Municipal Clinical Hospital No. 4 in November 2011. Immediate and long-term results show a rather high efficiency of using this operation in the treatment and prevention of bleeding from varicose veins of the esophagus with cirrhosis. It is advisable to conduct further studies of the effectiveness of using this operation, despite the encouraging results of the use of this modification of laparoscopic esophagogastric devascularization.
References
1. Tsochatzis E. A., Bosch J., Burroughs A. K. Liver cirrhosis // Lancet. 2014. Vol. 383. PP. 1749–1761.
2. De Franchis R., Baveno V Faculty. Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension // J Hepatol. 2015. Vol. 63. PP. 743–752.
3. Berzigotti A., Bosch J., Boyer T. D. Use of noninvasive markers of portal hypertension and timing of screening endoscopy for gastroesophageal varices in patients with chronic liver disease // Hepatology. 2014. Vol. 59. PP. 729–731.
4. Castaneda B., Morales J., Lionetti R. et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats // Hepatology. 2001. Vol. 33. PP. 821–825.
5. Garcia-Tsao G., Abraldes J. G., Berzigotti A., Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases // Hepatology. 2017. Vol. 65. PP. 310–335.
6. Bosch J., Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models // Hepatol Int. 2018. Vol. 12. Suppl 1. PP. 1–10.
7. Carbonell N., Pauwels A., Serfaty L. et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades // Hepatology. 2004. Vol. 40. PP. 652–659.
8. D’Amico G., De Franchis R. Cooperative Study G. Upper digestive bleeding in cirrhosis. Posttherapeutic outcome and prognostic indicators // Hepatology. 2003. Vol. 38. PP. 599–612.
9. Reverter E., Tandon P., Augustin S. et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding // Gastroenterology. 2014. Vol.
10. PP. 412–419.Xia S. S. (2006) Careful selection of splenectomy should be emphasized for cirrhotic portal hypertension. Chin J Hepatobiliary Surg. Vol. 12. PP. 583–584.
Review
For citations:
Mogilevets E. Treatment and prevention of bleeding from varicose veins of the esophagus. Science and Innovations. 2021;(1):80-81. (In Russ.) https://doi.org/10.29235/1818-9857-2021-1-80-83
Views: 83
Email this article 